Bracco and ulrich medical Establish Long-Term Alliance for Syringe-Free MRI Product Injectors

Friday, November 24, 2023

Bracco, a leader in global diagnostic imaging, and ulrich GmbH & Co. KG, a renowned German medical device manufacturer specializing in contrast injectors and spinal implants, have recently announced a comprehensive, long-term partnership. This collaboration is set to introduce Bracco's cutting-edge MRI product injector to the United States through an exclusive private label agreement. In a joint effort, the companies have submitted a 510(k) premarket notification to the FDA for the newly developed device by ulrich GmbH & Co. KG.

Distinguishing organs and tissues in medical imaging often requires the use of contrast media. With over three decades of experience, ulrich medical has been a key player in providing contrast injectors for computed tomography and magnetic resonance imaging. The FDA presentation of the injector, already approved by the European Medicines Agency and available in the European Union and numerous other countries, is a significant milestone in the collaboration between Bracco and ulrich medical.

Through their strategic partnership and private label agreement, Bracco aims to introduce syringe-free MRI product injectors to the United States. The recent submission of the 510(k) to the FDA represents a crucial advancement in elevating diagnostic imaging solutions nationwide and expanding Bracco's MRI portfolio in the United States. This collaboration reflects the shared commitment of Bracco Imaging and ulrich medical to fostering innovation and maintaining excellence in the healthcare sector.


Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital CongressHealthcare Innovation & Transformation SummitHealthcare CNO SummitHealthcare CMO SummitThe Healthcare Patient Experience & Engagement Summit 2024